115 related articles for article (PubMed ID: 11689148)
1. Loss of p73 induction in a cisplatin-resistant bladder cancer cell line.
Ono Y; Nonomura N; Harada Y; Fukui T; Tokizane T; Sato E; Nakayama M; Nishimura K; Takahara S; Okuyama A
Mol Urol; 2001; 5(1):25-30. PubMed ID: 11689148
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
3. [Effect of p73 gene on chemosensitivity of human lung adenocarcinoma cells H1299].
He Y; Fan SZ; Jiang YG; Chen JM; Li ZP; Zhou P; Zhou YG
Ai Zheng; 2004 Jun; 23(6):645-9. PubMed ID: 15191663
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
5. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
Ma Y; Yu WD; Trump DL; Johnson CS
Cancer; 2010 Jul; 116(13):3294-303. PubMed ID: 20564622
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
Muscolini M; Cianfrocca R; Sajeva A; Mozzetti S; Ferrandina G; Costanzo A; Tuosto L
Mol Cancer Ther; 2008 Jun; 7(6):1410-9. PubMed ID: 18566213
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.
Righetti SC; Perego P; Carenini N; Zunino F
Cancer Lett; 2008 May; 263(1):140-4. PubMed ID: 18261847
[TBL] [Abstract][Full Text] [Related]
8. p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.
Puig P; Capodieci P; Drobnjak M; Verbel D; Prives C; Cordon-Cardo C; Di Como CJ
Clin Cancer Res; 2003 Nov; 9(15):5642-51. PubMed ID: 14654547
[TBL] [Abstract][Full Text] [Related]
9. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
10. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
[TBL] [Abstract][Full Text] [Related]
11. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
[TBL] [Abstract][Full Text] [Related]
12. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage.
Gong JG; Costanzo A; Yang HQ; Melino G; Kaelin WG; Levrero M; Wang JY
Nature; 1999 Jun; 399(6738):806-9. PubMed ID: 10391249
[TBL] [Abstract][Full Text] [Related]
16. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
Bunch B; Krishnan N; Greenspan RD; Ramakrishnan S; Attwood K; Yan L; Qi Q; Wang D; Morrison C; Omilian A; Bshara W; Pili R; Trump DL; Johnson C; Woloszynska A
Cell Cycle; 2019 Sep; 18(17):2055-2066. PubMed ID: 31318640
[TBL] [Abstract][Full Text] [Related]
17. ATM-dependent nuclear accumulation of IKK-alpha plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin.
Yoshida K; Ozaki T; Furuya K; Nakanishi M; Kikuchi H; Yamamoto H; Ono S; Koda T; Omura K; Nakagawara A
Oncogene; 2008 Feb; 27(8):1183-8. PubMed ID: 17700524
[TBL] [Abstract][Full Text] [Related]
18. Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression.
Chen Z; Yang J; Wang G; Song B; Li J; Xu Z
Cancer Res; 2007 May; 67(10):4578-85. PubMed ID: 17510383
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
Mizutani Y; Wu XX; Yoshida O; Shirasaka T; Bonavida B
Oncol Rep; 1999; 6(5):979-82. PubMed ID: 10425290
[TBL] [Abstract][Full Text] [Related]
20. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
Mese H; Sasaki A; Nakayama S; Alcalde RE; Matsumura T
Cancer Chemother Pharmacol; 2000; 46(3):241-5. PubMed ID: 11021742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
